Genetic testing in benign familial epilepsies of the first year of life: Clinical and diagnostic significance
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Summary: Purpose: To dissect the genetics of benign familial epilepsies of the first year of life and to assess the extent of the genetic overlap between benign familial neonatal seizures (BFNS), benign familial neonatal‐infantile seizures (BFNIS), and benign familial infantile seizures (BFIS). Methods: Families with at least two first‐degree relatives affected by focal seizures starting within the first year of life and normal development before seizure onset were included. Families were classified as BFNS when all family members experienced neonatal seizures, BFNIS when the onset of seizures in family members was between 1 and 4 months of age or showed both neonatal and infantile seizures, and BFIS when the onset of seizures was after 4 months of age in all family members. SCN2A, KCNQ 2, KCNQ 3, PPRT 2 point mutations were analyzed by direct sequencing of amplified genomic DNA. Genomic deletions involving KCNQ 2 and KCNQ 3 were analyzed by multiple‐dependent probe amplification method. Key Findings: A total of 46 families including 165 affected members were collected. Eight families were classified as BFNS, 9 as BFNIS, and 29 as BFIS. Genetic analysis led to the identification of 41 mutations, 14 affecting KCNQ 2, 1 affecting KCNQ 3, 5 affecting SCN 2A, and 21 affecting PRRT 2. The detection rate of mutations in the entire cohort was 89%. In BFNS, mutations specifically involve KCNQ 2. In BFNIS two genes are involved (KCNQ 2, six families; SCN 2A, two families). BFIS families are the most genetically heterogeneous, with all four genes involved, although about 70% of them carry a PRRT 2 mutation. Significance: Our data highlight the important role of KCNQ 2 in the entire spectrum of disorders, although progressively decreasing as the age of onset advances. The occurrence of afebrile seizures during follow‐up is associated with KCNQ 2 mutations and may represent a predictive factor. In addition, we showed that KCNQ 3 mutations might be also involved in families with infantile seizures. Taken together our data indicate an important role of K‐channel genes beyond the typical neonatal epilepsies. The identification of a novel SCN 2A mutation in a family with infantile seizures with onset between 6 and 8 months provides further confirmation that this gene is not specifically associated with BFNIS and is also involved in families with a delayed age of onset. Our data indicate that PRRT 2 mutations are clustered in families with BFIS. Paroxysmal kinesigenic dyskinesia emerges as a distinctive feature of PRRT 2 families, although uncommon in our series. We showed that the age of onset of seizures is significantly correlated with underlying genetics, as about 90% of the typical BFNS families are linked to KCNQ 2 compared to only 3% of the BFIS families, for which PRRT 2 represents the major gene.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kumar, P., Henikoff, S., & Ng, P. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.86 · Cited by 6,521 · cited 1×
“…reported in familial early onset epilepsies and/or with clear-cut detrimental effect on protein structure (frameshift, nonsense, splice-site mutations, genomic deletions) or functionally damaging according to prediction software SIFT for missensemutations (SIFT score<0.05) (Kumar et al., 2009).”
InfluentialA novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns
Singh, N. A., Charlier, C., Stauffer, D., DuPont, B. R., Leach, R. J., Melis, R., Ronen, G. M., Bjerre, I., Quattlebaum, T., Murphy, J. V., et al. (1998) · Nature Genetics · doi:10.1038/ng0198-25 · Cited by 1,199 · cited 20×
“Genetic studies led to the identification ofmutations in the voltage-gated potassium channel genesKCNQ2 andKCNQ3 in BFNS (Singh et al., 1998; Biervert et al., 1998; Charlier et al., 1998) and in the voltage-gated sodium channel alpha2 subunit gene SCN2A in BFNIS (Heron et al., 2002; Berkovic et al., 2004), and a recen…”
InfluentialA Potassium Channel Mutation in Neonatal Human Epilepsy
Biervert, C., Schroeder, B. C., Kubisch, C., Berkovic, S. F., Propping, P., Jentsch, T. J., & Steinlein, O. K. (1998) · Science · doi:10.1126/science.279.5349.403 · Cited by 1,073 · cited 21×
“Genetic studies led to the identification ofmutations in the voltage-gated potassium channel genesKCNQ2 andKCNQ3 in BFNS (Singh et al., 1998; Biervert et al., 1998; Charlier et al., 1998) and in the voltage-gated sodium channel alpha2 subunit gene SCN2A in BFNIS (Heron et al., 2002; Berkovic et al., 2004), and a recen…”
InfluentialKCNQ2 encephalopathy: Emerging phenotype of a neonatal epileptic encephalopathy
Weckhuysen, S., Mandelstam, S., Suls, A., Audenaert, D., Deconinck, T., Claes, L. R. F., Deprez, L., Smets, K., Hristova, D., Yordanova, I., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22644 · Cited by 514
De novo mutations of voltage-gated sodium channel α II gene SCN2A in intractable epilepsies
Ogiwara, I., Ito, K., Sawaishi, Y., Osaka, H., Mazaki, E., Inoue, I., Montal, M., Hashikawa, T., Shike, T., Fujiwara, T., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b9cebc · Cited by 205
Cited by
Zuberi, S. M., Wirrell, E., Yozawitz, E., Wilmshurst, J. M., Specchio, N., Riney, K., Pressler, R., Auvin, S., Samia, P., Hirsch, E., et al. (2022) · Epilepsia · doi:10.1111/epi.17239 · Cited by 934
Self-citationGenetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders
Wolff, M., Johannesen, K. M., Hedrich, U. B. S., Masnada, S., Rubboli, G., Gardella, E., Lesca, G., Ville, D., Milh, M., Villard, L., et al. (2017) · Brain · doi:10.1093/brain/awx054 · Cited by 600
Self-citationPressler, R. M., Cilio, M. R., Mizrahi, E. M., Moshé, S. L., Nunes, M. L., Plouin, P., Vanhatalo, S., Yozawitz, E., de Vries, L. S., Puthenveettil Vinayan, K., et al. (2021) · Epilepsia · doi:10.1111/epi.16815 · Cited by 365
Progress in Understanding and Treating SCN2A-Mediated Disorders
Sanders, S. J., Campbell, A. J., Cottrell, J. R., Moller, R. S., Wagner, F. F., Auldridge, A. L., Bernier, R. A., Catterall, W. A., Chung, W. K., Empfield, J. R., et al. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.03.011 · Cited by 338
The evolving spectrum of PRRT2-associated paroxysmal diseases
Ebrahimi-Fakhari, D., Saffari, A., Westenberger, A., & Klein, C. (2015) · Brain · doi:10.1093/brain/awv317 · Cited by 270
Metadata
- Authors
- Zara, F., Specchio, N., Striano, P., Robbiano, A., Gennaro, E., Paravidino, R., Vanni, N., Beccaria, F., Capovilla, G., Bianchi, A., Caffi, L., Cardilli, V., Darra, F., Bernardina, B. D., Fusco, L., Gaggero, R., Giordano, L., Guerrini, R., Incorpora, G., Mastrangelo, M., Spaccini, L., Laverda, A. M., Vecchi, M., Vanadia, F., Veggiotti, P., Viri, M., Occhi, G., Budetta, M., Taglialatela, M., Coviello, D. A., Vigevano, F., & Minetti, C.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2013-01-29
- Volume
- 54
- Issue
- 3
- Pages
- 425-436
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W1969821462
- Cited by
- 126
- References
- 5
- FWCI
- 8.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic testing in benign familial epilepsies of the first year of life: Clinical and diagnostic significance. https://app.cochat.ai/papers/10.1111/epi.12089
- The paper
- Zara, F., Specchio, N., Striano, P., Robbiano, A., Gennaro, E., Paravidino, R., Vanni, N., Beccaria, F., Capovilla, G., Bianchi, A., Caffi, L., Cardilli, V., Darra, F., Bernardina, B. D., Fusco, L., Gaggero, R., Giordano, L., Guerrini, R., Incorpora, G., . . . Minetti, C. (2013). Genetic testing in benign familial epilepsies of the first year of life: Clinical and diagnostic significance. Epilepsia. https://doi.org/10.1111/epi.12089
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.